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Background
Crohn’s disease is an inflammatory bowel disease (IBD)
characterized by an augmentation of activated T cells and
a severe osteopenia due to an increased activity of osteo-
clasts, the bone-resorbing cells. Osteoclasts result from dif-
ferentiation of monocytes under the control of two
cytokines, RANK-L and M-CSF, produced by bone-form-
ing osteoblasts. Inflammatory cytokines produced by
T cells have been shown to increase osteoclatogenesis,
leading to osteopenia. The aim of this study is to identify
CD4+ T cells implicated in osteolysis.
Material and methods
We used a murine model of IBD associated with severe
osteopenia, the IL-10-/- mouse to analyze the phenotype
and function of bone marrow (BM) CD4+ T cells.
Results
We showed that CD4+ T cells isolated from the BM of IL-
10-/- mice with IBD induced in vitro the differentiation of
osteoclasts. The analysis in BM of the Th subsets present
among these CD4+ T cells revealed, in addition to Th1, a
population producing both TNF-a and IL-17, cytokines
known to increase osteoclastogenesis. Our results showed
that sorted CD4+ IL-17+ TNFa+ T cells increased the
production of RANK-L by osteoblasts and induce the dif-
ferentiation of osteoclasts in vitro. Furthermore, this popu-
lation led to the recruitment of monocytes (pre-
osteoclasts) in the BM in vivo participating thereby to the
increased osteoclastogenesis. Altogether, the induction of
RANK-L and monocyte recruitment by CD4+ IL-17+
TNFa+ T cells may represent a possible mechanism of
osteolysis in vivo. Lastly, we found the CD4+ IL-17+
TNFa+ population in the blood of patients with Crohn’s
disease, but not in controls and experiments are in pro-
gress to confirm the osteoclastogenic role of this popula-
tion in human.
Conclusion
Altogether, our results showed for the first time that
CD4+ IL-17+ TNFa+ cells represent an osteoclatogenic T
cell subset present in vivo, and potentially responsible for
osteopenia in mice and Crohn’s patients.
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